BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35216497)

  • 21. One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases.
    Van Voorhis WC; Hulverson MA; Choi R; Huang W; Arnold SLM; Schaefer DA; Betzer DP; Vidadala RSR; Lee S; Whitman GR; Barrett LK; Maly DJ; Riggs MW; Fan E; Kennedy TJ; Tzipori S; Doggett JS; Winzer P; Anghel N; Imhof D; Müller J; Hemphill A; Ferre I; Sanchez-Sanchez R; Ortega-Mora LM; Ojo KK
    Vet Parasitol; 2021 Jan; 289():109336. PubMed ID: 33418437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Toxicities among Different Bumped Kinase Inhibitor Analogs for Treatment of Cryptosporidiosis.
    Hulverson MA; Choi R; Schaefer DA; Betzer DP; McCloskey MC; Whitman GR; Huang W; Lee S; Pranata A; McLeod MD; Marsh KC; Kempf DJ; LeRoy BE; Zafiratos MT; Bielinski AL; Hackman RC; Ojo KK; Arnold SLM; Barrett LK; Tzipori S; Riggs MW; Fan E; Van Voorhis WC
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0142522. PubMed ID: 36920244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy.
    Ojo KK; Dangoudoubiyam S; Verma SK; Scheele S; DeRocher AE; Yeargan M; Choi R; Smith TR; Rivas KL; Hulverson MA; Barrett LK; Fan E; Maly DJ; Parsons M; Dubey JP; Howe DK; Van Voorhis WC
    Int J Parasitol; 2016 Dec; 46(13-14):871-880. PubMed ID: 27729271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The gatekeeper residue and beyond: homologous calcium-dependent protein kinases as drug development targets for veterinarian Apicomplexa parasites.
    Keyloun KR; Reid MC; Choi R; Song Y; Fox AMW; Hillesland HK; Zhang Z; Vidadala R; Merritt EA; Lau AOT; Maly DJ; Fan E; Barrett LK; Van Voorhis WC; Ojo KK
    Parasitology; 2014 Sep; 141(11):1499-1509. PubMed ID: 24927073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host cells participate in the in vitro effects of novel diamidine analogues against tachyzoites of the intracellular apicomplexan parasites Neospora caninum and Toxoplasma gondii.
    Leepin A; Stüdli A; Brun R; Stephens CE; Boykin DW; Hemphill A
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1999-2008. PubMed ID: 18362190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of Cryptosporidiosis.
    Hulverson MA; Choi R; Vidadala RSR; Whitman GR; Vidadala VN; Ojo KK; Barrett LK; Lynch JJ; Marsh K; Kempf DJ; Maly DJ; Van Voorhis WC
    ACS Infect Dis; 2021 May; 7(5):1200-1207. PubMed ID: 33565854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bumped kinase inhibitor 1294 treats established Toxoplasma gondii infection.
    Doggett JS; Ojo KK; Fan E; Maly DJ; Van Voorhis WC
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3547-9. PubMed ID: 24687502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoproteomics to identify species-specific antigens in Neospora caninum recognised by infected bovine sera.
    Udonsom R; Reamtong O; Adisakwattana P; Popruk S; Jirapattharasate C; Nishikawa Y; Inpankaew T; Toompong J; Kotepui M; Mahittikorn A
    Parasite; 2022; 29():60. PubMed ID: 36562441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of Mitochondrial Energy Metabolism by Glutaredoxin 5 in the Apicomplexan Parasite Neospora caninum.
    Song X; Yang X; Ying Z; Wu K; Liu J; Liu Q
    Microbiol Spectr; 2023 Feb; 11(1):e0309122. PubMed ID: 36541793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced treatment frequencies with bumped kinase inhibitor 1369 are effective against porcine cystoisosporosis.
    Shrestha A; Ruttkowski B; Greber P; Whitman GR; Hulverson MA; Choi R; Michaels SA; Ojo KK; Van Voorhis WC; Joachim A
    Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():37-45. PubMed ID: 32861205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis.
    Schaefer DA; Betzer DP; Smith KD; Millman ZG; Michalski HC; Menchaca SE; Zambriski JA; Ojo KK; Hulverson MA; Arnold SL; Rivas KL; Vidadala RS; Huang W; Barrett LK; Maly DJ; Fan E; Van Voorhis WC; Riggs MW
    J Infect Dis; 2016 Dec; 214(12):1856-1864. PubMed ID: 27923949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
    Huang W; Hulverson MA; Choi R; Arnold SLM; Zhang Z; McCloskey MC; Whitman GR; Hackman RC; Rivas KL; Barrett LK; Ojo KK; Van Voorhis WC; Fan E
    J Med Chem; 2019 Mar; 62(6):3135-3146. PubMed ID: 30830766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bumped kinase inhibitor prohibits egression in Babesia bovis.
    Pedroni MJ; Vidadala RS; Choi R; Keyloun KR; Reid MC; Murphy RC; Barrett LK; Van Voorhis WC; Maly DJ; Ojo KK; Lau AO
    Vet Parasitol; 2016 Jan; 215():22-8. PubMed ID: 26790733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neospora caninum Dense Granule Protein 7 Regulates the Pathogenesis of Neosporosis by Modulating Host Immune Response.
    Nishikawa Y; Shimoda N; Fereig RM; Moritaka T; Umeda K; Nishimura M; Ihara F; Kobayashi K; Himori Y; Suzuki Y; Furuoka H
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006392
    [No Abstract]   [Full Text] [Related]  

  • 35. Atovaquone, chloroquine, primaquine, quinine and tetracycline: antiproliferative effects of relevant antimalarials on Neospora caninum.
    Pereira LM; de Luca G; Abichabki NLM; Brochi JCV; Baroni L; Abreu-Filho PG; Yatsuda AP
    Rev Bras Parasitol Vet; 2021; 30(1):e022120. PubMed ID: 33787719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological diagnosis of bovine neosporosis by Neospora caninum monoclonal antibody-based competitive inhibition enzyme-linked immunosorbent assay.
    Baszler TV; Knowles DP; Dubey JP; Gay JM; Mathison BA; McElwain TF
    J Clin Microbiol; 1996 Jun; 34(6):1423-8. PubMed ID: 8735092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of novel rhoptry proteins in Neospora caninum by LC/MS-MS analysis of subcellular fractions.
    Marugán-Hernández V; Alvarez-García G; Tomley F; Hemphill A; Regidor-Cerrillo J; Ortega-Mora LM
    J Proteomics; 2011 May; 74(5):629-42. PubMed ID: 21315855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annotating the 'hypothetical' in hypothetical proteins: In-silico analysis of uncharacterised proteins for the Apicomplexan parasite, Neospora caninum.
    Calarco L; Ellis J
    Vet Parasitol; 2019 Jan; 265():29-37. PubMed ID: 30638518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of ribosomal phosphoprotein P0 of Neospora caninum as a potential common vaccine candidate for the control of both neosporosis and toxoplasmosis.
    Zhang H; Lee EG; Liao M; Compaore MK; Zhang G; Kawase O; Fujisaki K; Sugimoto C; Nishikawa Y; Xuan X
    Mol Biochem Parasitol; 2007 Jun; 153(2):141-8. PubMed ID: 17412435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential Affinity Chromatography Coupled to Mass Spectrometry: A Suitable Tool to Identify Common Binding Proteins of a Broad-Range Antimicrobial Peptide Derived from Leucinostatin.
    Müller J; Boubaker G; Imhof D; Hänggeli K; Haudenschild N; Uldry AC; Braga-Lagache S; Heller M; Ortega-Mora LM; Hemphill A
    Biomedicines; 2022 Oct; 10(11):. PubMed ID: 36359195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.